Watching Tumours Gasp and Die with MRI: the Promise of Hyperpolarised 13C MR Spectroscopic Imaging

Overview

Journal Br J Radiol

Publisher Oxford University Press

Specialty Radiology

Date 2012 Apr 13

PMID 22496072

Citations 16

Authors

K Brindle

Affiliations

Soon will be listed here.

Abstract

A better understanding of tumour biology has led to the development of "targeted therapies", in which a drug is designed to disrupt a specific biochemical pathway important for tumour cell survival or proliferation. The introduction of these drugs into the clinic has shown that patients can vary widely in their responses. Molecular imaging is likely to play an increasingly important role in predicting and detecting these responses and thus in guiding treatment in individual patients: so-called "personalised medicine". The aim of this review is to discuss how hyperpolarised (13)C MR spectroscopic imaging might be used for treatment response monitoring. This technique, which increases the sensitivity of detection of injected (13)C-labelled molecules by >10,000-fold, has allowed a new approach to metabolic imaging. The basic principles of the technique and its potential advantages over other imaging methods for detecting early evidence of treatment response will be discussed. Given that the technique is poised to translate to the clinic, I will also speculate on its likely applications.

Citing Articles

Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance.

Salzillo T, Mawoneke V, Weygand J, Shetty A, Gumin J, Zacharias N Cells. 2021; 10(10).

PMID: 34685601 PMC: 8534002. DOI: 10.3390/cells10102621.

DCE-MRI of Brain Fluid Barriers: Water Cycling at the Human Choroid Plexus.

Anderson V, Tagge I, Doud A, Li X, Springer Jr C, Quinn J Tissue Barriers. 2021; 10(1):1963143.

PMID: 34542012 PMC: 8794257. DOI: 10.1080/21688370.2021.1963143.

A multi spin echo pulse sequence with optimized excitation pulses and a 3D cone readout for hyperpolarized C imaging.

Somai V, Wright A, Fala M, Hesse F, Brindle K Magn Reson Med. 2020; 84(4):1895-1908.

PMID: 32173908 PMC: 8638674. DOI: 10.1002/mrm.28248.

A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures.

Cox B, Erickson-Bhatt S, Szulczewski J, Squirrell J, Ludwig K, Macdonald E Magn Reson Med. 2019; 81(5):3379-3391.

PMID: 30652350 PMC: 6414270. DOI: 10.1002/mrm.27644.

Analysis of C and C labeling in pyruvate and lactate in tumor and blood of lymphoma-bearing mice injected with C- and C-labeled pyruvate.

Serrao E, Kettunen M, Rodrigues T, Lewis D, Gallagher F, Hu D NMR Biomed. 2018; 31(5):e3901.

PMID: 29457661 PMC: 5947589. DOI: 10.1002/nbm.3901.

References

Gadian D, Radda G . NMR studies of tissue metabolism. Annu Rev Biochem. 1981; 50:69-83. DOI: 10.1146/annurev.bi.50.070181.000441. View

Vivanco I, Sawyers C . The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002; 2(7):489-501. DOI: 10.1038/nrc839. View

Cunningham C, Chen A, Albers M, Kurhanewicz J, Hurd R, Yen Y . Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson. 2007; 187(2):357-62. DOI: 10.1016/j.jmr.2007.05.014. View

Golman K, Petersson J . Metabolic imaging and other applications of hyperpolarized 13C1. Acad Radiol. 2006; 13(8):932-42. DOI: 10.1016/j.acra.2006.06.001. View

Brindle K . New approaches for imaging tumour responses to treatment. Nat Rev Cancer. 2008; 8(2):94-107. DOI: 10.1038/nrc2289. View

Qu W, Zha Z, Lieberman B, Mancuso A, Stetz M, Rizzi R . Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Acad Radiol. 2011; 18(8):932-9. DOI: 10.1016/j.acra.2011.05.002. View

Mayer D, Levin Y, Hurd R, Glover G, Spielman D . Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med. 2006; 56(4):932-7. DOI: 10.1002/mrm.21025. View

Krishnan A, Neves A, de Backer M, Hu D, Davletov B, Kettunen M . Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent. Radiology. 2008; 246(3):854-62. DOI: 10.1148/radiol.2463070471. View

Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2008; 45(2):228-47. DOI: 10.1016/j.ejca.2008.10.026. View

10.

Ardenkjaer-Larsen J, Leach A, Clarke N, Urbahn J, Anderson D, Skloss T . Dynamic nuclear polarization polarizer for sterile use intent. NMR Biomed. 2011; 24(8):927-32. DOI: 10.1002/nbm.1682. View

11.

Day S, Kettunen M, Gallagher F, Hu D, Lerche M, Wolber J . Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med. 2007; 13(11):1382-7. DOI: 10.1038/nm1650. View

12.

. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007; 37(2-4):1-332. DOI: 10.1016/j.icrp.2007.10.003. View

13.

MacKenzie J, Yen Y, Mayer D, Tropp J, Hurd R, Spielman D . Detection of inflammatory arthritis by using hyperpolarized 13C-pyruvate with MR imaging and spectroscopy. Radiology. 2011; 259(2):414-20. PMC: 3079121. DOI: 10.1148/radiol.10101921. View

14.

Choi H, Charnsangavej C, de Castro Faria S, Tamm E, Benjamin R, Johnson M . CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol. 2004; 183(6):1619-28. DOI: 10.2214/ajr.183.6.01831619. View

15.

Schroeder M, Cochlin L, Heather L, Clarke K, Radda G, Tyler D . In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci U S A. 2008; 105(33):12051-6. PMC: 2515222. DOI: 10.1073/pnas.0805953105. View

16.

Park I, Larson P, Zierhut M, Hu S, Bok R, Ozawa T . Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol. 2010; 12(2):133-44. PMC: 2940577. DOI: 10.1093/neuonc/nop043. View

17.

Day S, Kettunen M, Cherukuri M, Mitchell J, Lizak M, Morris H . Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging. Magn Reson Med. 2011; 65(2):557-63. PMC: 3690628. DOI: 10.1002/mrm.22698. View

18.

Miller J, Pien H, Sahani D, Sorensen A, Thrall J . Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst. 2005; 97(3):172-87. DOI: 10.1093/jnci/dji023. View

19.

Kwock L, Smith J, Castillo M, Ewend M, Collichio F, Morris D . Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. Lancet Oncol. 2006; 7(10):859-68. DOI: 10.1016/S1470-2045(06)70905-6. View

20.

Prescher J, Contag C . Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol. 2009; 14(1):80-9. DOI: 10.1016/j.cbpa.2009.11.001. View